The AfriKADIA consortium Phase III trial on a short regimen to treat the neglected tropical disease visceral leishmaniasis is highlighted in Nature Medicine as one of 11 clinical trials that will shape medicine in 2022.
- Projects
-
Our work
Clinical research & developmentStrengthening research capacitySupporting researchers
-
Funding
How we fund researchGuidance and templates
-
News & resources
News & storiesResourcesEvents
-
About us
How we work
©2022 The European & Developing Countries Clinical Trials Partnership.
Cookie settings
We use cookies on our website to enhance your browsing experience, analyze site traffic, and personalize content. By clicking "Accept All," you consent to the use of all cookies. However, you may visit "Cookie Settings" to provide controlled consent.